N,N'-Di(4-pyridyl)-1,4,5,8-naphthalenetetracarboxdiimide>98.0%(HPLC)(N)1g

5-fluoro-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 250mg

Pritelivir, 99.03%, 10mg

1-(2-(4-Methylpiperazin-1-yl)ethyl)-1h-pyrazol-4-amine, 98%, 5g

1-(3,4-Dimethylphenyl)prop-2-en-1-amine, 1g

Glass vials with rolled rim Tall, 25 ml, Height, 50 mm, 200 Piece(s)

Fuming hydrochloric acid, 37%, pa, 500 ml, glass packaging

(S)-3-(tert-Butylamino)propane-1,2-diol, 95.0%, 25g

1-(3,5-Difluorophenyl)cyclobutan-1-ol, 98%, 5g

7-Bromo-2,2-dimethyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine, 98%, 500mg

4-Chloro-5-fluoro-2-nitrophenol, 97.0%, 5g

Dimethyl 4,5-difluorophthalate, 98%, 1g

2-Fluorobenzamide, 98.0%, 100g